Investigations into Sterility Failures What do you do when you find out there is  a problem with a  sterility test?
Investigations into Sterility Failures Answer: It depends on  your perspective
Investigations into Sterility Failures A.  You Cry If you’re the technician
Investigations into Sterility Failures The Technician I failed No one will trust me I could be fired
Investigations into Sterility Failures B.  You Deny it If you’re the lab director
Investigations into Sterility Failures The Lab Director Who messed up? What about training? Will I be blamed? There goes my bonus
Investigations into Sterility Failures C.  You get ready to  reject the product If you’re QA
Investigations into Sterility Failures QA The FDA is coming We have a disaster Shut down the place Reject first, ask questions later
Investigations into Sterility Failures D.  You blame  someone else If you’re the manufacturer
Investigations into Sterility Failures The Manufacturer I can’t trust anyone Other products involved? There goes our incentive Now we have to spend money to do it right.  Damn!
Investigations into Sterility Failures E.  You Panic If you’re the client
Investigations into Sterility Failures The Client I’ll lose money I’ll lose credibility I might lose my business
Investigations into Sterility Failures How do you reconcile  all these concerns? Methodically Lab Manufacturer, supplier Management
Investigations into Sterility Failures The Lab Technician Spore strips (media run) First time alone Identified organism Not  B. stearothermophilis Retest passed
Investigations into Sterility Failures The Lab Director Direct inoculation  (cotton) Isolated Gram negative Could not find the source Notified client Lost the account
Investigations into Sterility Failures QA Spore strip (Bandage) B. subtilis  found Lab investigation ETO sterilization review: Excursions in cycle Material rejected
Investigations into Sterility Failures The Manufacturer Sterilant: propylene oxide Isolated Gram negative Lab investigation Manufacturing investigation Excipient supplier investigation: Excessive bioburden Product recalled Heads rolled (management)
Investigations into Sterility Failures The Client Sterile ampule sterility failure We  panicked  Manufacturer  blamed the lab Lab  blamed the manufacturer QA  ready to reject Life was getting interesting
Investigations into Sterility Failures The Client Antibiotic in plastic ampule  First failure ever (3 years)  Propriobacterium acnes   Lab investigation OK Recent merger
Investigations into Sterility Failures Product History  Three year clean tract record Human-associated organism Product was inhibitory Did not make sense: validated Convinced management to wait
Investigations into Sterility Failures Why would I want  to save the batch? Could I do anything  to save the batch?
Investigations into Sterility Failures FDA Out-of-Specification  (OOS) guidance? It essentially excludes microbiological and  biological assays
Investigations into Sterility Failures ICH Q7A OOS guidance? States that OOS  investigations are  not necessary for  in-process tests
Investigations into Sterility Failures USP <1117>? Discusses the difficulties associated with resolving  a Microbial Data  Deviation (MDD)   Not much help
Investigations into Sterility Failures FDA Aseptic Processing Guidance  Provides a rational, methodical, scientific approach  to address  the issue
Investigations into Sterility Failures “ Only if conclusive and documented evidence  clearly shows that contamination occurred  as part of testing should  a new test be performed”
Investigations into Sterility Failures “ When available evidence is inconclusive batches  should be rejected as not conforming  to sterility  requirements”
Investigations into Sterility Failures Needed a smoking gun
Investigations into Sterility Failures Lab? Manufacturer? Supplier? Management?
Investigations into Sterility Failures The initial steps Place product on hold Are other batches affected? Write an investigation protocol based on the criteria  outlined in the  Aseptic Processing Guideline
Investigations into Sterility Failures Detail exactly what should be done Seven specific areas that need to be investigated
Investigations into Sterility Failures 1.  Identify the organism Review lab tests and deviations Review production area EM data Review lab and production  personnel training and history i i
Investigations into Sterility Failures Review product bioburden Review production records Review manufacturing history  (including media fills) i i
Investigations into Sterility Failures We added four more areas to investigate
Investigations into Sterility Failures 8.  Review the API source 9.  Review the excipient sources 10.  Review  weighing facility  11.  Review contract laboratory
Investigations into Sterility Failures We placed the onus of the investigation on the laboratory operation, aligning it with an  MDD investigation
Investigations into Sterility Failures We had eleven areas to find the smoking gun We told management we could do it
Investigations into Sterility Failures Now it was up to us  (aka me) to find  the source of  contamination
Investigations into Sterility Failures Wrote the protocol  Had it countersigned by senior  management in my company,  the manufacture and the contract  laboratory  We needed the full cooperation of all parties in order to thoroughly conduct the investigation
Investigations into Sterility Failures 1.  Identification :   Propriobacterium acnes - associated with human activity Confirmed by GC analysis
Investigations into Sterility Failures 2.  Review of laboratory tests and deviations   Reviewed sterility test history of  the  contract laboratory for 3 years Sterility failure rate and false positive rate < 0.1%  Organism not found in the past
Investigations into Sterility Failures 3.  Production area environment 3 years of EM data reviewed  Organism found 18 months ago on air sampling plate  Not found in sterile shroud Not associated with any sterility or environmental issues
Investigations into Sterility Failures Personnel Monitoring   (laboratory and production) Organism not found on either  the laboratory or production personnel in the past  three years
Investigations into Sterility Failures 5.  Product bioburden  Past 3 years reviewed, one instance it exceeded limit of  < 10 CFU/100 mL This organism was not isolated Bioburden found only once or twice a year; each time organism was  Bacillus.   All the  other times bioburden  < 10 CFU/100 mL  Biofouling occurred 5 years ago, rectified  with CIP 100 after media fills
Investigations into Sterility Failures 6.  Review of Batch Records All records from the past 3 years All excursions addressed during the runs Current record was also re-reviewed and no excursions of any type were found
Investigations into Sterility Failures Manufacturing history   No bioburden (other than the aforementioned), personnel or  EM excursions in last 3 years Manufacturing area pristine,  personnel well trained and  man-in-the-plant for every batch Media fills (15,000 ampules each of  TSB and FTM) done 2X/year, No +
Investigations into Sterility Failures Additional Areas
Investigations into Sterility Failures API source Microbial limit testing performed  on every batch of API by both the  overseas manufacture and the US contract laboratory
Investigations into Sterility Failures The microbiological history reviewed for 3 years and  Propriobacterium acnes  never found
Investigations into Sterility Failures Occasionally  Bacillus  found in API at  levels below the specification of  <15 CFU/gm  and appeared infrequently in the pre-sterilization bioburden
Investigations into Sterility Failures 9.  Excipients MLT done on every excipient lot Microbiological history reviewed for  3 years.  P. acnes  not found Other than WFI, excipients were corrosive or not conducive to growth of this organism
Investigations into Sterility Failures 10. W eighing facility   (NJ) Every area thoroughly scrutinized: receiving area, holding area,  weighing room, transfer area, shipping area, analytical labs  Weighing room trend data  < 2 CFU per settling plate site Organism not found in three years
Investigations into Sterility Failures 11.  Contract laboratory   Contract lab scrutinized: receiving area, staging area, anteroom, sterility suite, cleaning processes, HEPA filters, personnel, autoclave cycles, purchased media, sterility equipment, incubators, EM isolates
Investigations into Sterility Failures Anything remotely associated with the product was scrutinized Organism not isolated, 3 year data  Documentation provided complete cross referencing to media prep, sterilization, growth promotion, organism maintenance, EM, cleaning and (most importantly) training
Investigations into Sterility Failures The bottom line: Great data, No smoking gun
Investigations into Sterility Failures Weakest link was the sterility test What more could I do? Management was very impatient
Investigations into Sterility Failures Convinced management  to do a study
Investigations into Sterility Failures Shipped finished product from the plant to the  lab for testing
Investigations into Sterility Failures Watched every step of the operation:  Receiving and logging of FP  Storing the product Preparing it for testing, staging it and transferring it into the sterility suite
Investigations into Sterility Failures I even gowned up with the technicians and stood behind them while  they performed  the sterility test
Investigations into Sterility Failures Everything was perfect  I couldn’t find the smoking gun and was resigned to the fact that we would have to reject  the batch without any  definitive root cause
Investigations into Sterility Failures There was one glimmer  of hope, however
Investigations into Sterility Failures During the sterility test 20 ampules were pooled into a sterile container  Sterile containers sterilized by gamma radiation  Shipped in a large cardboard box containing a polyethylene bag filled with 1000 sterile containers
Investigations into Sterility Failures Why weren’t the containers  individually wrapped?  Less expensive to  buy them in bulk
Investigations into Sterility Failures The lab recently switched from individually  wrapped containers  to bulk packaged containers
Investigations into Sterility Failures Sampled the inside,  outside and flaps  of the cardboard  box, and the  polyethylene  bag
Investigations into Sterility Failures Two samples contained  Propriobacterium acnes
Investigations into Sterility Failures The smoking gun?
Investigations into Sterility Failures YES!
Investigations into Sterility Failures Residing in the cardboard box that contained the sample containers  used to pool the  product before  filtration!
Investigations into Sterility Failures We had our evidence to  invalidate the original test The lab purchased individually wrapped sample containers,  invalidated the original  sterility test, performed  a successful  retest
Investigations into Sterility Failures We released the product based upon the results of the retest, the completion of the investigation by my company, the contract  manufacturer and the contract laboratory
Investigations into Sterility Failures Lessons learned: ●  Don’t panic  ●  Let science be your guide ●  Prepare a sound action plan  ●  Involve all stakeholders  ●  Keep searching for a cause ●  Be brave ●  Don’t give up
Investigations into Sterility Failures Questions?
Investigations into Sterility Failures Thank you Frank Settineri Veracorp LLC 973-729-8171 [email_address]
Investigations into Sterility Failures References 1  www.microbiologyforum.org/PMFNews/PMFNew s.12.11.0611.pdf   2  www.fda.gov/cder/guidance/3634fnl.htm   OOS 3  www.fda.gov/Cber/gdlns/ichactive.pdf   ICH OOS 4  USP, <1117>  Best Microbiological Practice  USP 29  Supplement 2, 2006 Guideline 5  www.fda.gov/cder/guidance/5882fnl.pdf   Aseptic guidance

Investigations Into Sterility Failures

  • 1.
    Investigations into SterilityFailures What do you do when you find out there is a problem with a sterility test?
  • 2.
    Investigations into SterilityFailures Answer: It depends on your perspective
  • 3.
    Investigations into SterilityFailures A. You Cry If you’re the technician
  • 4.
    Investigations into SterilityFailures The Technician I failed No one will trust me I could be fired
  • 5.
    Investigations into SterilityFailures B. You Deny it If you’re the lab director
  • 6.
    Investigations into SterilityFailures The Lab Director Who messed up? What about training? Will I be blamed? There goes my bonus
  • 7.
    Investigations into SterilityFailures C. You get ready to reject the product If you’re QA
  • 8.
    Investigations into SterilityFailures QA The FDA is coming We have a disaster Shut down the place Reject first, ask questions later
  • 9.
    Investigations into SterilityFailures D. You blame someone else If you’re the manufacturer
  • 10.
    Investigations into SterilityFailures The Manufacturer I can’t trust anyone Other products involved? There goes our incentive Now we have to spend money to do it right. Damn!
  • 11.
    Investigations into SterilityFailures E. You Panic If you’re the client
  • 12.
    Investigations into SterilityFailures The Client I’ll lose money I’ll lose credibility I might lose my business
  • 13.
    Investigations into SterilityFailures How do you reconcile all these concerns? Methodically Lab Manufacturer, supplier Management
  • 14.
    Investigations into SterilityFailures The Lab Technician Spore strips (media run) First time alone Identified organism Not B. stearothermophilis Retest passed
  • 15.
    Investigations into SterilityFailures The Lab Director Direct inoculation (cotton) Isolated Gram negative Could not find the source Notified client Lost the account
  • 16.
    Investigations into SterilityFailures QA Spore strip (Bandage) B. subtilis found Lab investigation ETO sterilization review: Excursions in cycle Material rejected
  • 17.
    Investigations into SterilityFailures The Manufacturer Sterilant: propylene oxide Isolated Gram negative Lab investigation Manufacturing investigation Excipient supplier investigation: Excessive bioburden Product recalled Heads rolled (management)
  • 18.
    Investigations into SterilityFailures The Client Sterile ampule sterility failure We panicked Manufacturer blamed the lab Lab blamed the manufacturer QA ready to reject Life was getting interesting
  • 19.
    Investigations into SterilityFailures The Client Antibiotic in plastic ampule First failure ever (3 years) Propriobacterium acnes Lab investigation OK Recent merger
  • 20.
    Investigations into SterilityFailures Product History Three year clean tract record Human-associated organism Product was inhibitory Did not make sense: validated Convinced management to wait
  • 21.
    Investigations into SterilityFailures Why would I want to save the batch? Could I do anything to save the batch?
  • 22.
    Investigations into SterilityFailures FDA Out-of-Specification (OOS) guidance? It essentially excludes microbiological and biological assays
  • 23.
    Investigations into SterilityFailures ICH Q7A OOS guidance? States that OOS investigations are not necessary for in-process tests
  • 24.
    Investigations into SterilityFailures USP <1117>? Discusses the difficulties associated with resolving a Microbial Data Deviation (MDD) Not much help
  • 25.
    Investigations into SterilityFailures FDA Aseptic Processing Guidance Provides a rational, methodical, scientific approach to address the issue
  • 26.
    Investigations into SterilityFailures “ Only if conclusive and documented evidence clearly shows that contamination occurred as part of testing should a new test be performed”
  • 27.
    Investigations into SterilityFailures “ When available evidence is inconclusive batches should be rejected as not conforming to sterility requirements”
  • 28.
    Investigations into SterilityFailures Needed a smoking gun
  • 29.
    Investigations into SterilityFailures Lab? Manufacturer? Supplier? Management?
  • 30.
    Investigations into SterilityFailures The initial steps Place product on hold Are other batches affected? Write an investigation protocol based on the criteria outlined in the Aseptic Processing Guideline
  • 31.
    Investigations into SterilityFailures Detail exactly what should be done Seven specific areas that need to be investigated
  • 32.
    Investigations into SterilityFailures 1. Identify the organism Review lab tests and deviations Review production area EM data Review lab and production personnel training and history i i
  • 33.
    Investigations into SterilityFailures Review product bioburden Review production records Review manufacturing history (including media fills) i i
  • 34.
    Investigations into SterilityFailures We added four more areas to investigate
  • 35.
    Investigations into SterilityFailures 8. Review the API source 9. Review the excipient sources 10. Review weighing facility 11. Review contract laboratory
  • 36.
    Investigations into SterilityFailures We placed the onus of the investigation on the laboratory operation, aligning it with an MDD investigation
  • 37.
    Investigations into SterilityFailures We had eleven areas to find the smoking gun We told management we could do it
  • 38.
    Investigations into SterilityFailures Now it was up to us (aka me) to find the source of contamination
  • 39.
    Investigations into SterilityFailures Wrote the protocol Had it countersigned by senior management in my company, the manufacture and the contract laboratory We needed the full cooperation of all parties in order to thoroughly conduct the investigation
  • 40.
    Investigations into SterilityFailures 1. Identification : Propriobacterium acnes - associated with human activity Confirmed by GC analysis
  • 41.
    Investigations into SterilityFailures 2. Review of laboratory tests and deviations Reviewed sterility test history of the contract laboratory for 3 years Sterility failure rate and false positive rate < 0.1% Organism not found in the past
  • 42.
    Investigations into SterilityFailures 3. Production area environment 3 years of EM data reviewed Organism found 18 months ago on air sampling plate Not found in sterile shroud Not associated with any sterility or environmental issues
  • 43.
    Investigations into SterilityFailures Personnel Monitoring (laboratory and production) Organism not found on either the laboratory or production personnel in the past three years
  • 44.
    Investigations into SterilityFailures 5. Product bioburden Past 3 years reviewed, one instance it exceeded limit of < 10 CFU/100 mL This organism was not isolated Bioburden found only once or twice a year; each time organism was Bacillus. All the other times bioburden < 10 CFU/100 mL Biofouling occurred 5 years ago, rectified with CIP 100 after media fills
  • 45.
    Investigations into SterilityFailures 6. Review of Batch Records All records from the past 3 years All excursions addressed during the runs Current record was also re-reviewed and no excursions of any type were found
  • 46.
    Investigations into SterilityFailures Manufacturing history No bioburden (other than the aforementioned), personnel or EM excursions in last 3 years Manufacturing area pristine, personnel well trained and man-in-the-plant for every batch Media fills (15,000 ampules each of TSB and FTM) done 2X/year, No +
  • 47.
    Investigations into SterilityFailures Additional Areas
  • 48.
    Investigations into SterilityFailures API source Microbial limit testing performed on every batch of API by both the overseas manufacture and the US contract laboratory
  • 49.
    Investigations into SterilityFailures The microbiological history reviewed for 3 years and Propriobacterium acnes never found
  • 50.
    Investigations into SterilityFailures Occasionally Bacillus found in API at levels below the specification of <15 CFU/gm and appeared infrequently in the pre-sterilization bioburden
  • 51.
    Investigations into SterilityFailures 9. Excipients MLT done on every excipient lot Microbiological history reviewed for 3 years. P. acnes not found Other than WFI, excipients were corrosive or not conducive to growth of this organism
  • 52.
    Investigations into SterilityFailures 10. W eighing facility (NJ) Every area thoroughly scrutinized: receiving area, holding area, weighing room, transfer area, shipping area, analytical labs Weighing room trend data < 2 CFU per settling plate site Organism not found in three years
  • 53.
    Investigations into SterilityFailures 11. Contract laboratory Contract lab scrutinized: receiving area, staging area, anteroom, sterility suite, cleaning processes, HEPA filters, personnel, autoclave cycles, purchased media, sterility equipment, incubators, EM isolates
  • 54.
    Investigations into SterilityFailures Anything remotely associated with the product was scrutinized Organism not isolated, 3 year data Documentation provided complete cross referencing to media prep, sterilization, growth promotion, organism maintenance, EM, cleaning and (most importantly) training
  • 55.
    Investigations into SterilityFailures The bottom line: Great data, No smoking gun
  • 56.
    Investigations into SterilityFailures Weakest link was the sterility test What more could I do? Management was very impatient
  • 57.
    Investigations into SterilityFailures Convinced management to do a study
  • 58.
    Investigations into SterilityFailures Shipped finished product from the plant to the lab for testing
  • 59.
    Investigations into SterilityFailures Watched every step of the operation: Receiving and logging of FP Storing the product Preparing it for testing, staging it and transferring it into the sterility suite
  • 60.
    Investigations into SterilityFailures I even gowned up with the technicians and stood behind them while they performed the sterility test
  • 61.
    Investigations into SterilityFailures Everything was perfect I couldn’t find the smoking gun and was resigned to the fact that we would have to reject the batch without any definitive root cause
  • 62.
    Investigations into SterilityFailures There was one glimmer of hope, however
  • 63.
    Investigations into SterilityFailures During the sterility test 20 ampules were pooled into a sterile container Sterile containers sterilized by gamma radiation Shipped in a large cardboard box containing a polyethylene bag filled with 1000 sterile containers
  • 64.
    Investigations into SterilityFailures Why weren’t the containers individually wrapped? Less expensive to buy them in bulk
  • 65.
    Investigations into SterilityFailures The lab recently switched from individually wrapped containers to bulk packaged containers
  • 66.
    Investigations into SterilityFailures Sampled the inside, outside and flaps of the cardboard box, and the polyethylene bag
  • 67.
    Investigations into SterilityFailures Two samples contained Propriobacterium acnes
  • 68.
    Investigations into SterilityFailures The smoking gun?
  • 69.
  • 70.
    Investigations into SterilityFailures Residing in the cardboard box that contained the sample containers used to pool the product before filtration!
  • 71.
    Investigations into SterilityFailures We had our evidence to invalidate the original test The lab purchased individually wrapped sample containers, invalidated the original sterility test, performed a successful retest
  • 72.
    Investigations into SterilityFailures We released the product based upon the results of the retest, the completion of the investigation by my company, the contract manufacturer and the contract laboratory
  • 73.
    Investigations into SterilityFailures Lessons learned: ● Don’t panic ● Let science be your guide ● Prepare a sound action plan ● Involve all stakeholders ● Keep searching for a cause ● Be brave ● Don’t give up
  • 74.
    Investigations into SterilityFailures Questions?
  • 75.
    Investigations into SterilityFailures Thank you Frank Settineri Veracorp LLC 973-729-8171 [email_address]
  • 76.
    Investigations into SterilityFailures References 1 www.microbiologyforum.org/PMFNews/PMFNew s.12.11.0611.pdf 2 www.fda.gov/cder/guidance/3634fnl.htm OOS 3 www.fda.gov/Cber/gdlns/ichactive.pdf ICH OOS 4 USP, <1117> Best Microbiological Practice USP 29 Supplement 2, 2006 Guideline 5 www.fda.gov/cder/guidance/5882fnl.pdf Aseptic guidance